Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome

Objective To evaluate the anatomical and visual outcomes of patients treated with ocriplasmin for the treatment of symptomatic vitreomacular adhesion (sVMA), including vitreomacular traction syndrome and macular holes. Design Retrospective, interventional, single centre, case series. Participants Pa...

Full description

Saved in:

Bibliographic Details
Published in:	British journal of ophthalmology Vol. 98; no. 3; pp. 356 - 360
Main Authors:	Singh, Rishi P, Li, Ang, Bedi, Rumneek, Srivastava, Sunil, Sears, Jonathan E, Ehlers, Justis P, Schachat, Andrew P, Kaiser, Peter K
Format:	Journal Article
Language:	English
Published:	England BMJ Publishing Group LTD 01.03.2014
Subjects:	Age Aged Aged, 80 and over Clinical trials Diabetic retinopathy Eye Diseases - drug therapy Eye Diseases - metabolism Eye Diseases - pathology Female Fibrinolysin - adverse effects Fibrinolysin - therapeutic use Fibrinolytic Agents - adverse effects Fibrinolytic Agents - therapeutic use Humans Intravitreal Injections Macular degeneration Male Middle Aged Peptide Fragments - adverse effects Peptide Fragments - therapeutic use Retinal Perforations - drug therapy Retinal Perforations - metabolism Retinal Perforations - pathology Retrospective Studies Syndrome Tissue Adhesions - drug therapy Tissue Adhesions - metabolism Tissue Adhesions - pathology Tomography Tomography, Optical Coherence Treatment Outcome Visual Acuity - physiology Vitreous Body - drug effects Vitreous Body - metabolism Vitreous Body - pathology Optic Nerve
ISSN:	0007-1161, 1468-2079, 1468-2079
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!